When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MLNT - Melinta Gains Speedy Review For Expanded Application
Melinta Therapeutics Inc - Ordinary Shares
Melinta Therapeutics (MLNT) stock soared more than 200% on Wednesday, after it had announced that its supplemental New Drug Application (sNDA) was accepted by the FDA. The application seeks to expand the market opportunity for its drug BAXDELA. What also caused the stock to soar higher likely was the fact that the drug was given priority review. Being that the company mainly deals with developing antibiotics, there are several risk factors to watch out for. I believe that Melinta might be worth a trade for the run-up towards a potential FDA decision.